Literature DB >> 6816332

Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis.

M F Martin, J E Tooke.   

Abstract

The effects of prostaglandin E1 infusion on nailfold capillary haemodynamics were studied in eight patients with Raynaud's phenomenon secondary to progressive systemic sclerosis. Using a modified Landis microinjection technique the mean (+/- SEM) transcapillary pressure gradient was increased during and six weeks after infusion by 13.9 +/- 3.2 cm H2O (p less than 0.05) and 5.5 +/- 2.5 cm H2O (p less than 0.05) respectively. Capillary red cell velocity measured in two patients by video television microscopy also increased during and after infusion with prostaglandin E1. Six patients claimed subjective benefit and in three their ulcers healed. These findings support the observed beneficial effect of prostaglandin E1 and suggest that it improves the nutritive capillary circulation by lowering precapillary resistance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816332      PMCID: PMC1500707          DOI: 10.1136/bmj.285.6356.1688

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Pathogenesis of systemic sclerosis: a vascular hypothesis.

Authors:  P M Campbell; E C LeRoy
Journal:  Semin Arthritis Rheum       Date:  1975-05       Impact factor: 5.532

2.  Medical uses of intra-arterial injections of reserpine. Treatment of Raynaud syndrome and of some vascular insufficiencies of the lower extremities.

Authors:  J P Tindall; R E Whalen; E E Burton
Journal:  Arch Dermatol       Date:  1974-08

3.  Nail-fold capillaries in connective-tissue disorders.

Authors:  I S Buchanan; D J Humpston
Journal:  Lancet       Date:  1968-04-20       Impact factor: 79.321

4.  Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique.

Authors:  A Bollinger; P Butti; J P Barras; H Trachsler; W Siegenthaler
Journal:  Microvasc Res       Date:  1974-01       Impact factor: 3.514

5.  The skin microcirculation and the pathogenesis of ischaemic necrosis and gangrene.

Authors:  B Fagrell
Journal:  Scand J Clin Lab Invest       Date:  1977-10       Impact factor: 1.713

6.  Nail fold capillaroscopy--a useful aid in the diagnosis of collagen vascular diseases.

Authors:  J B Ross
Journal:  J Invest Dermatol       Date:  1966-10       Impact factor: 8.551

7.  Arterial thrombosis in scleroderma.

Authors:  N L Furey; F R Schmid; H C Kwaan; H H Friederici
Journal:  Br J Dermatol       Date:  1975-12       Impact factor: 9.302

8.  Treatment of Raynaud's phenomenon by fibrinolytic enhancement.

Authors:  P E Jarrett; M Morland; N L Browse
Journal:  Br Med J       Date:  1978-08-19

Review 9.  Vascular disease in progressive systemic sclerosis (scleroderma).

Authors:  W L Norton; J M Nardo
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

10.  Skin capillary blood flow in scleroderma.

Authors:  E C LeRoy; J A Downey; P J Cannon
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more
  6 in total

Review 1.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.

Authors:  J Keller; A Kaltenecker; K T Schricker; B Neidhardt; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Remission of secondary Raynaud phenomenon using intra-arterial prostaglandin E1 infusion. A case report.

Authors:  J Seemann; J Scholz; M Sielwicz
Journal:  Int Orthop       Date:  1994       Impact factor: 3.075

4.  Assessment of platelet function in patients with Raynaud's syndrome.

Authors:  R A Hutton; D P Mikhailidis; R M Bernstein; J Y Jeremy; G R Hughes; P Dandona
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

Review 5.  Systemic sclerosis--a microvascular disorder?

Authors:  M I Jayson
Journal:  J R Soc Med       Date:  1983-08       Impact factor: 18.000

Review 6.  Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment.

Authors:  Shirin Assar; Hosna Khazaei; Maryam Naseri; Fardous El-Senduny; Saeideh Momtaz; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  J Immunol Res       Date:  2021-06-24       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.